title: CEU:Managing menopausal symptoms after the women's health initiative.
abstract: Until the results of the Women's Health Initiative (WHI) were released in July 2002, hormone replacement therapy (HRT) had been thought to be the most effective way to manage unwanted menopausal symptoms and to prevent long-term health problems associated with aging. The results of the WHI, showing that HRT is less beneficial and associated with more risks than previously thought, has complicated the management of unwanted menopausal symptoms. This article discusses the effectiveness of HRT and other modalities used to relieve menopausal symptoms and discusses how to choose an HRT product to match specific menopausal complaints and provide maximum safety.
authors.affiliation: barbara.hackley@yale.edu
authors.forename: Barbara
authors.initials: B
authors.lastname: Hackley
authors.forename: Mary Ellen
authors.initials: ME
authors.lastname: Rousseau
mesh_terms: D000368:Aged; D000375:Aging / Q000187:drug effects / Q000502:physiology; D001943:Breast Neoplasms / Q000139:chemically induced / Q000517:prevention & control; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000139:chemically induced / Q000517:prevention & control; D015914:Estrogen Replacement Therapy / Q000009:adverse effects / Q000592:standards; D005260:Female; D019584:Hot Flashes / Q000517:prevention & control; D006801:Humans; D008593:Menopause / Q000187:drug effects / Q000502:physiology; D008875:Middle Aged; D018570:Risk Assessment; D012307:Risk Factors; D012449:Safety; D007319:Sleep Initiation and Maintenance Disorders / Q000517:prevention & control; D020521:Stroke / Q000139:chemically induced / Q000517:prevention & control; D014549:Urinary Incontinence / Q000517:prevention & control; D014623:Vaginal Diseases / Q000517:prevention & control